Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
about
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillationEffectiveness of systematic screening for the detection of atrial fibrillationDirect thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with non-valvular atrial fibrillationEffectiveness of systematic screening for the detection of atrial fibrillationMechanisms and management of stroke in the elderly.A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN893A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]Systematic screening for the detection of atrial fibrillationCellular and Molecular Mechanisms of Arrhythmia by Oxidative StressCognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney diseaseAtrial fibrillation: a review of recent studies with a focus on those from the duke clinical research instituteCare transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safety2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Surgical Ablation of Atrial Fibrillation Using Energy SourcesPercutaneous left atrial appendage closure devices: safety, efficacy, and clinical utilityHeart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group ReportCardiac Plug I and Amulet Devices: Left Atrial Appendage Closure for Stroke Prophylaxis in Atrial FibrillationTrends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research databaseAtrial fibrillation and stroke preventionUnderuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in ItalyDrug therapy for atrial fibrillationAnticoagulation in atrial fibrillationComorbidity associated with atrial fibrillation: a general practice-based studyIs warfarin really underused in patients with atrial fibrillation?Screening for atrial fibrillation in primary careAtrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.Use of an interdisciplinary, participatory design approach to develop a usable patient self-assessment tool in atrial fibrillationFeasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF)Potassium channel gene mutations rarely cause atrial fibrillationQuality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care.Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years.Long-term anticoagulation. Indications and management.Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 PatientsIdentification of patients with atrial fibrillation in general practice: a study of screening methods.Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot studyQuality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.
P2860
Q24197843-2C3E43BC-4A10-442E-82DD-D83ED0D9D6AEQ24197923-17675BE8-D755-4A6C-A624-B101E760B7E1Q24202488-AA595FC6-02FD-48A8-8E98-1223BB6F2012Q24203942-D199A643-8470-43E8-9925-104AD8283245Q24537145-D34EBBB8-7C31-411F-B6D7-D8AE3174BDFFQ24798085-49294BA2-025B-4147-81BD-3B9E44A22D4FQ24801915-7BF609CC-72B0-49C9-8A58-422151D8B738Q24803243-4A2567C2-2B0F-4D8F-BD40-8EDCC32435AFQ26471549-79F94E46-A049-4117-918A-BFAA8804A6C3Q26765076-40709B23-A545-4751-819C-E60F35800D0AQ26799394-FFF59497-64AB-4AB4-8955-ED85D0FDB68DQ26801625-B6110798-590D-4DA0-B628-6AACD66C475EQ26851235-C236DF8E-C2BE-4E04-B6AD-FD4A50E59271Q27025527-D2B7F3E9-621D-49CD-86DE-D19CD05F809DQ27341873-76FE3461-B2F4-47F8-97E5-001DB3F131ABQ28069595-BF014D8E-1222-4C00-ADA0-A4F1AE5D7854Q28071688-C37C9A91-F605-4165-9FE9-C130D86EB3F3Q28078934-FDDAFF16-66E1-4D70-A3C2-9A9B6F677DECQ28081426-1F2144A5-0076-479F-80B5-8036A63D859CQ28188181-C4EDD82B-53ED-4754-8FB7-91B74E360CB3Q28201536-BB8C1348-FFDF-4531-9E3D-163CB558F6CDQ28212575-EE7C82EE-1B67-467C-8F7C-58F8F6CBF785Q28218580-C5D54896-319D-49DD-B3BE-41388C83EB2CQ28315636-9B1B6E05-CFA7-4244-920C-486B24175CA7Q28344172-F56DA542-F0F8-4E08-B9E7-119D24C119BCQ28365245-EA6D327F-4164-4F78-8282-1EEA95B575C3Q28379391-C7EAC210-3695-4226-934E-5C58D9B1337FQ30541348-E27A6D87-70A9-45CC-AD2D-804EA6EB0011Q30557089-16E096C6-621B-48FF-9CD1-39A31438C856Q33165613-28459006-7510-4549-B15A-4D23309552E2Q33252748-EFE84E9E-A904-460E-AAEA-6B848B90966FQ33297454-C6CFD924-5A99-4701-A682-059C3142C50CQ33572430-A2A7CF0B-F622-4E15-A9AC-21F01939072AQ33599340-65FC799D-22A0-455E-8DAA-60C6487ADF2EQ33617257-F204F7B2-E012-4C96-BD6A-4A2B915B86F3Q33755738-FF737B2C-7DE3-4581-8E33-C9CC9F5276E7Q33792405-1BFA9334-A817-4E1E-9CA0-E40D025A3C40Q33823381-257C04C6-B13E-4267-BE69-04E7F6096826Q33889600-49A07258-5B9D-4DC1-A8B3-EAB7AC2F4851Q33891646-BF1E763E-791E-4833-9042-3E0523A93B60
P2860
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@ast
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@en
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@nl
type
label
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@ast
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@en
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@nl
prefLabel
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@ast
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@en
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@nl
P2093
P1476
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.
@en
P2093
P304
P356
10.1001/ARCHINTE.1987.00370090041008
P407
P577
1987-09-01T00:00:00Z